research product . Other ORP type . 2017

MERS-coronavirus: From discovery to intervention

Widagdo, Widagdo; Okba, Nisreen; Stalin Raj, V.; Haagmans, Bart;
Open Access English
  • Published: 01 Jun 2017
  • Country: Netherlands
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) still causes outbreaks despite public awareness and implementation of health care measures, such as rapid viral diagnosis and patient quarantine. Here we describe the current epidemiological picture of MERS-CoV, focusing on humans and animals affected by this virus and propose specific intervention strategies that would be appropriate to control MERS-CoV. One-third of MERS-CoV patients develop severe lower respiratory tract infection and succumb to a fatal outcome; these patients would require effective therapeutic antiviral therapy. Because of the lack of such intervention strategies, supportive care is the best that can be offered at the moment. Limiting viral spread from symptomatic human cases to health care workers and family members, on the other hand, could be achieved through prophylactic administration of MERS-CoV neutralizing antibodies and vaccines. To ultimately prevent spread of the virus into the human population, however, vaccination of dromedary camels – currently the only confirmed animal host for MERS-CoV – may be the best option to achieve a sustained drop in human MERS cases in time. In the end, a One Health approach combining all these different efforts is needed to tackle this zoonotic outbreak.
Persistent Identifiers
Subjects
Medical Subject Headings: viruses
free text keywords: Coronavirus, Dromedary camel, Intervention, MERS, Review
Related Organizations
Communities
  • COVID-19
Funded by
EC| ZAPI
Project
ZAPI
Zoonotic Anticipation and Preparedness Initiative
  • Funder: European Commission (EC)
  • Project Code: 115760
  • Funding stream: FP7 | SP1 | SP1-JTI
Download from
Open Access
NARCIS
Other ORP type . 2017
Providers: NARCIS
88 references, page 1 of 6

[1] A. Zumla, D.S. Hui, S. Perlman, Middle East respiratory syndrome, Lancet 386 (2015) 995-1007.

[2] V.D. Menachery, B.L. Yount Jr., K. Debbink, et al., A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence, Nat. Med. 21 (2015) 1508-1513. [OpenAIRE]

[3] A.M. Zaki, S. van Boheemen, T.M. Bestebroer, A.D. Osterhaus, R.A. Fouchier, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N. Engl. J. Med. 367 (2012) 1814-1820.

[4] G.M. Leung, A.J. Hedley, L.M. Ho, et al., The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients, Ann. Intern. Med. 141 (2004) 662-673.

[5] C. Drosten, B. Meyer, M.A. Muller, et al., Transmission of mers-coronavirus in household contacts, N. Engl. J. Med. 371 (2014) 828-835.

[6] The Who Mers-Cov Research G, State of knowledge and data gaps of Middle East respiratory syndrome corona virus (MERS-COV) in humans, PLoS Curr. 5 (2013).

[7] A.M. Ajlan, R.A. Ahyad, L.G. Jamjoom, A. Alharthy, T.A. Madani, Middle East respiratory syndrome coronavirus (MERS-COV) infection: chest CT findings, AJR Am. J. Roentgenol. 203 (2014) 782-787. [OpenAIRE]

[8] S. van Boheemen, M. de Graaf, C. Lauber, et al., Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans, MBio 3 (2012).

[9] V.M. Corman, I. Eckerle, T. Bleicker, et al., Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction, Euro Surveill. 17 (2012). [OpenAIRE]

[10] V.M. Corman, M.A. Muller, U. Costabel, et al., Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections, Euro Surveill. 17 (2012).

[11] X. Lu, B. Whitaker, S.K. Sakthivel, et al., Real-time reverse transcription-pcr assay panel for Middle East respiratory syndrome coronavirus, J. Clin. Microbiol. 52 (2014) 67-75.

[12] A.S. Aburizaiza, F.M. Mattes, E.I. Azhar, et al., Investigation of anti-Middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012, J. Infect. Dis. 209 (2014) 243-246.

[13] C.B. Reusken, B.L. Haagmans, M.A. Muller, et al., Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study, Lancet Infect. Dis. 13 (2013) 859-866. [OpenAIRE]

[14] A.N. Alagaili, T. Briese, N. Mishra, et al., Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia, MBio 5 (2014) e00884-e008814.

[15] M.A. Muller, B. Meyer, V.M. Corman, et al., Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study, Lancet Infect. Dis. 15 (2015) 559-564.

88 references, page 1 of 6
Any information missing or wrong?Report an Issue